Dallas/Fort Worth, TX (July 23, 2015) — Neos Therapeutics, Inc. (“Neos” or “the Company”) today announced the pricing of its initial public offering of 4,800,000 shares of common stock at an initial public offering price of $15.00 per share. In addition, Neos has granted the underwriters a 30-day option to purchase up to an additional 720,000 shares of common stock at the initial public offering... (read more)

ATLANTA, July 9, 2015 /PRNewswire/ -- Femasys Inc., a developer of innovative medical devices for the women's healthcare market, announced today that it has secured a term loan facility from Silicon Valley Bank.  Under the loan facility, the company ... (read more)

After bringing in one of the top venture capital investments during first quarter 2015, Neos Therapeutics has filed for an initial public offering.  The Grand Prairie-based company, which develops medication for Attention Deficit/Hyperactivity Disorder, filed Friday to trade on the Nasdaq under ticker symbol NEOS. It has a place holder value... (read more)

LOS ANGELES--(BUSINESS WIRE)--Cynvenio Biosystems, Inc., the pioneer in LiquidBiopsy technology for the genomic analysis of tumor cells from whole blood in support of cancer precision medicine strategies, announced today the completion... (read more)

LOS ANGELES, Calif., June 10, 2015 (LA TIMES) -- Robert Redford's Sundance Cinemas is putting itself up for sale.  Sundance Cinemas said in a statement that it has hired the investment bank Salem Partners to find a buyer for the small L.A.-based theater chain.  Sundance Cinemas is part of several entities overseen by Redford... (read more)

REDWOOD CITY, Calif., May 26, 2015 (GLOBE NEWSWIRE) -- ZS Pharma, Inc. (Nasdaq:ZSPH), a biopharmaceutical company focused on the development and commercialization of highly selective, non-absorbed drugs to treat renal, cardiovascular, liver and metabolic disorders, today announced that it has submitted a New Drug Application (NDA) to... (read more)

Atlanta, GA -April 29, 2015 - Femasys Inc., a developer of innovative medical devices for the women's healthcare market has raised a $10.2 million financing round. The investor group was led by Legacy Capital Partners and Mario Family Partners, the family offices of... (read more)

LOS ANGELES, CA, April 22, 2015 -- Salem Partners is pleased to announce the completion of a $500 million programmatic joint-venture in the real estate / parking sector for its client, Parking Acquisition Venture (PAVe). PAVe is a partnership between Propark America and Parkit and... (read more)

Emblematic of the state of the financial world, former Federal Reserve Chairman Ben Bernanke is taking an advisory role with Citadel, the $25 billion hedge fund based in Chicago. Making less of a splash but certainly worth pointing out, Bernanke follows...(read more)

CHESTERFIELD, Mich., Dec. 10, 2014 /PRNewswire/ -- The Burtek Group ("Burtek") has acquired Process Fab, Inc. ("PFI") based inSanta Fe Springs, CA. The combination of Votaw Precision Technologies, Inc. ("Votaw") and PFI under the Burtek portfolio, brings together two of the best spaceflight and aerospace suppliers in the industry and creates a... (read more)

DALLAS, Texas, JACKSONVILLE, Florida, and SAVANNAH, Tennessee, October 15, 2014 - Trive Capital ("Trive"), the Dallas-based private equity firm, is proud to announce its investments in Merlin RAMCo, LLC ("Merlin") and ISR Group LLC ("ISR"). Headquartered in Jacksonville, Florida, Merlin is a leading... (read more)

Gardena, CA (October 7, 2014) Impresa Aerospace, a leading supplier to the commercial and military aerospace industries, announced today that it has been acquired by a private equity fund managed by Twin Haven... (read more)

Millennium Entertainment, the distribution arm of Avi Lerner's Nu Image, officially went up for sale back in April 2013. Now there is a deal from within after entities like Luc Besson's EuropaCorp kicked the tires: The Millennium Entertainment management team led by CEO Bill Lee and private investment firm Virgo Investment Group are... (read more)

Private equity-backed Valence Technologies has acquired Pride Plating, Dynamic Paint Solutions and Coastline Metal Finishing.  Pride, headquartered in Tulsa, Oklahoma, provides processing and sub-assembly for large aluminum and titanium structures, specifically for aircrafts... (read more)

Salem Partners LLC, a boutique investment bank and wealth management firm, announced the addition of real estate veterans Jeff Barcy and Sean Lenz to its team in April. The pair hailed from Cantor Fitzgerald & Co., where Barcy ran the national real estate investment banking practice. Barcy recently spoke with SNL about his new position and his plans to focus on raising private... (read more)

COPPELL, Texas, July 8, 2014 (GLOBE NEWSWIRE) -- ZS Pharma, a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, announced today that it has received Notices of Allowance from the U.S. Patent and Trademark...(read more) 

COPPELL, Texas--(BUSINESS WIRE)--ZS Pharma, Inc., a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, today announced the closing of its initial public offering of 6,836,111 shares of common stock at a public offering price of $18.00 per share. This includes the exercise in...(read more)

COPPELL, Texas--(BUSINESS WIRE)--ZS Pharma, Inc., a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, today announced the pricing of its initial public offering of 5,944,444 shares of its common stock at a price to the public of $18.00 per share. The shares are expected to begin... (read more)

In corporate development there are few investable and actionable certainties. Here today, in 2014, we face one of the most significant certainties that operators and investors will encounter for decades to come – the comprehensive redesign of the health services and life sciences industries.

In this healthcare & life sciences report, we highlight today’s growth areas and opportunities, with an aim to provide insight into current trends and business drivers. This report explores the shifts taking place within the US healthcare industry to enable stakeholders to formulate better decisions and strategies. Our overarching goal is to ensure that providers, investors and corporate development professionals remain well-placed to realize healthy returns. (read more)

DALLAS/FORT WORTH, Texas, Apr 23, 2014 (BUSINESS WIRE) -- Neos Therapeutics, Inc. (“Neos” or “the Company”),a highly differentiated oral drug delivery company with an exciting portfolio of proprietary technologies and a late-stage pipeline of innovative controlled release (CR) products for ADHD, announced today that it has entered into a $20 million loan facility with Hercules... (read more)

LOS ANGELES, CA - April 2014 - Salem Partners, a Los Angeles-based investment bank and wealth management firm, is pleased to announce the hiring of real estate industry veterans Jeff Barcy and Sean Lenz. The new team will focus on private capital raising for top real estate operators in the U.S. This effort will include joint venture equity and private debt placements, sourced from the team's deep relationships with... (read more)

Dallas private equity firm Trive Capital has combined Coast Plating Inc. and Chrome Plus International Inc. to form Valence Surface Technologies.  Valence is an independently owned aerospace and defense metal processing company. Terms of the deal were not disclosed.  Coast Plating, headquartered in Los Angeles., provides metal processing and finishing... (read more)

COPPELL, Texas--(BUSINESS WIRE)--ZS Pharma, a specialty pharmaceutical company developing novel treatments for kidney, cardiovascular, and liver disorders, today announced that it has completed a $55 million Series D financing. The investor syndicate was led by Novo A/S and included new investors RA Capital, Adage Capital, Sofinnova Ventures, and... (read more)

DALLAS/FORT WORTH, Texas--(BUSINESS WIRE)--Neos Therapeutics, Inc. (“Neos” or “the Company”), a highly differentiated oral drug delivery company with an exciting portfolio of proprietary technologies and a late-stage pipeline of innovative controlled release (CR) products for ADHD, announced today that it has completed an oversubscribed round of private financing, raising a total... (read more)

As Boeing and Airbus demand more finishing capacity, the challenges faced by owners of finishing businesses are pressing, as both customers and regulatory agencies amp up demands for management attention and resources.  The surface finishing industry is experiencing a business environment unlike anything seen in the last... (read more)